Literature DB >> 9076713

Multiprimed cDNA synthesis followed by PCR is the most suitable method for Epstein-Barr virus transcript analysis in small lymphoma biopsies.

A A Brink1, J J Oudejans, M Jiwa, J M Walboomers, C J Meijer, A J van den Brule.   

Abstract

In this study, the reverse transcriptase-polymerase chain reaction (RT-PCR) for the reliable detection of multiple Epstein-Barr virus (EBV) transcripts was optimized and subsequently evaluated on lymphoma specimens. Since often only small lymphoma biopsies are available for analysis of EBV transcripts, several RT-protocols to generate cDNA from multiple targets were applied. These were multi-primer, oligo-dT primed and random hexamer primed cDNA synthesis. Multi-primer cDNA synthesis appeared to be the most suitable method for subsequent PCR analysis of EBV targets; simultaneous priming with up to 10 specific antisense primers (for EBNA1 and 2, LMP1 and 2, BARF0, BHRF1, BZLF1, C promoter activity and the RNA control genes U1A and c-abl) followed by PCR showed no loss of sensitivity compared to single-specific antisense priming. Transcripts were specifically detected in up to one EBV-positive JY cell in a background of 50,000 EBV-negative BJAB cells, with the exception of BZLF1 and QK spliced EBNA1 transcripts which could only be detected in 1000 and 10,000 EBV-positive cells, respectively. The analytical sensitivities of all the primers used in PCR, including BZLF1 and QK EBNA1 primers, were 1-10 copies of cloned RT-PCR products. The multi-primed RT-PCR was evaluated on lymphomas (n = 13). In cases with proper RNA quality, EBV expression patterns found were identical to those found in previous studies using single-primed RT-PCR assays. In conclusion, this study shows that multi-primed RT-PCR analysis can be used efficiently for EBV transcript analysis in small lymphoma biopsies, thereby facilitating studies concerning the role of EBV in lymphomagenesis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9076713     DOI: 10.1006/mcpr.1996.0074

Source DB:  PubMed          Journal:  Mol Cell Probes        ISSN: 0890-8508            Impact factor:   2.365


  8 in total

Review 1.  Molecular diagnosis of Epstein-Barr virus-related diseases.

Authors:  M L Gulley
Journal:  J Mol Diagn       Date:  2001-02       Impact factor: 5.568

2.  Activity of the EBNA1 promoter associated with lytic replication (Fp) in Epstein-Barr virus associated disorders.

Authors:  A A Brink; C J Meijer; J M Nicholls; J M Middeldorp; A J van den Brule
Journal:  Mol Pathol       Date:  2001-04

3.  Expression of Epstein-Barr virus (EBV) transcripts encoding homologues to important human proteins in diverse EBV associated diseases.

Authors:  D P Hayes; A A Brink; M B Vervoort; J M Middeldorp; C J Meijer; A J van den Brule
Journal:  Mol Pathol       Date:  1999-04

4.  Transcript Analysis of White spot syndrome virus Latency and Phagocytosis Activating Protein Genes in Infected Shrimp (Penaeus monodon).

Authors:  M S Shekhar; M Dillikumar; K Vinaya Kumar; G Gopikrishna; S Rajesh; J Kiruthika; A G Ponniah
Journal:  Indian J Virol       Date:  2012-11-27

5.  Evaluation of two set of primers for detection of immediate early gene UL123 of human cytomegalovirus (HCMV).

Authors:  Massimiliano Bergallo; Cristina Costa; Maria Elena Terlizzi; Samuela Margio; Francesca Sidoti; Franca Sinesi; Rossana Cavallo
Journal:  Mol Biotechnol       Date:  2007-08-25       Impact factor: 2.695

6.  Nucleic acid sequence-based amplification, a new method for analysis of spliced and unspliced Epstein-Barr virus latent transcripts, and its comparison with reverse transcriptase PCR.

Authors:  A A Brink; M B Vervoort; J M Middeldorp; C J Meijer; A J van den Brule
Journal:  J Clin Microbiol       Date:  1998-11       Impact factor: 5.948

7.  Dried-blood sampling for epstein-barr virus immunoglobulin G (IgG) and IgA serology in nasopharyngeal carcinoma screening.

Authors:  J Fachiroh; P R Prasetyanti; D K Paramita; A T Prasetyawati; D W Anggrahini; S M Haryana; J M Middeldorp
Journal:  J Clin Microbiol       Date:  2008-02-06       Impact factor: 5.948

8.  The intron-enriched HERV-K(HML-10) family suppresses apoptosis, an indicator of malignant transformation.

Authors:  Felix Broecker; Roger Horton; Jochen Heinrich; Alexandra Franz; Michal-Ruth Schweiger; Hans Lehrach; Karin Moelling
Journal:  Mob DNA       Date:  2016-12-07
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.